These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 20571134

  • 1. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Pinsky PF, Blacka A, Kramer BS, Miller A, Prorok PC, Berg C.
    Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
    [Abstract] [Full Text] [Related]

  • 2. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK, PLCO Project Team.
    J Natl Cancer Inst; 2005 Mar 16; 97(6):433-8. PubMed ID: 15770007
    [Abstract] [Full Text] [Related]

  • 3. Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.
    Pinsky PF, Andriole GL, Kramer BS, Hayes RB, Prorok PC, Gohagan JK, Prostate, Lung, Colorectal and Ovarian Project Team.
    J Urol; 2005 Mar 16; 173(3):746-50; discussion 750-1. PubMed ID: 15711261
    [Abstract] [Full Text] [Related]

  • 4. Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.
    Pinsky PF, Crawford ED, Kramer BS, Andriole GL, Gelmann EP, Grubb R, Greenlee R, Gohagan JK.
    BJU Int; 2007 Apr 16; 99(4):775-9. PubMed ID: 17223921
    [Abstract] [Full Text] [Related]

  • 5. Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial.
    Crawford ED, Pinsky PF, Chia D, Kramer BS, Fagerstrom RM, Andriole G, Reding D, Gelmann EP, Levin DL, Gohagan JK.
    J Urol; 2006 Apr 16; 175(4):1286-90; discussion 1290. PubMed ID: 16515981
    [Abstract] [Full Text] [Related]

  • 6. Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam.
    Beemsterboer PM, de Koning HJ, Kranse R, Trienekens PH, van der Maas PJ, Schröder FH.
    J Urol; 2000 Oct 16; 164(4):1216-20. PubMed ID: 10992369
    [Abstract] [Full Text] [Related]

  • 7. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
    Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC, PLCO Project Team.
    J Natl Cancer Inst; 2012 Jan 18; 104(2):125-32. PubMed ID: 22228146
    [Abstract] [Full Text] [Related]

  • 8. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Grubb RL, Black A, Izmirlian G, Hickey TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg CD, Crawford ED, Church TR, Andriole GL, PLCO Project Team.
    Cancer Epidemiol Biomarkers Prev; 2009 Mar 18; 18(3):748-51. PubMed ID: 19258472
    [Abstract] [Full Text] [Related]

  • 9. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I, Weiss NS, Lin DW, Stanford JL.
    Cancer Causes Control; 2007 Nov 18; 18(9):931-7. PubMed ID: 17641982
    [Abstract] [Full Text] [Related]

  • 10. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH.
    Can J Urol; 2005 Feb 18; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X, van Leeuwen PJ, Bul M, Otto SJ, de Koning HJ, Bangma CH, Schröder FH, Roobol MJ.
    Eur Urol; 2011 Aug 18; 60(2):330-6. PubMed ID: 21601352
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characteristics of prostate cancer detected by digital rectal examination only.
    Okotie OT, Roehl KA, Han M, Loeb S, Gashti SN, Catalona WJ.
    Urology; 2007 Dec 18; 70(6):1117-20. PubMed ID: 18158030
    [Abstract] [Full Text] [Related]

  • 17. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R.
    Can J Urol; 2011 Oct 18; 18(5):5875-83. PubMed ID: 22018148
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.
    Gosselaar C, Roobol MJ, Roemeling S, Schröder FH.
    Eur Urol; 2008 Sep 18; 54(3):581-8. PubMed ID: 18423977
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.